American Society of Hematology, Blood, 11(132), p. 1193-1197
DOI: 10.1182/blood-2018-01-829523
Full text: Unavailable
Key Points The fusion between FVIII and anti-VWF nanobodies increases affinity for VWF 25-fold without compromising FVIII activity. Stabilized VWF binding results in a twofold enhanced circulatory survival of FVIII and reduced anti-FVIII antibody formation.